Meeting
2023 ASCO Annual Meeting
A machine learning–based multidimensional model integrating clinical, radiomics, and cell-free DNA methylation biomarkers for the classification of pulmonary nodules.
Authors
Wenhua Liang
Department of Thoracic Surgery/Esophageal Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
Wenhua Liang , Bo Wang , Jinsheng Tao , Minhua Peng , Xixiang Tu , Xiangcheng Qiu , Yang Yang , Zhujia Ye , Zhiwei Chen , Jianbing Fan , Jianxing He
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Clinical Trial Registration Number
NCT03181490, NCT03651986
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3070)
DOI
10.1200/JCO.2023.41.16_suppl.3070
Abstract #
3070
Poster Bd #
268
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Deep neural networks to predict pathological invasiveness through surgical resection images: A computer vision based prospective clinical trial in pulmonary nodules.
First Author: Henian Yao
Poster
2023 ASCO Annual Meeting
Liquid biopsy in combination with PET/CT versus PET/CT alone in diagnosis of lung cancer in small nodules.
First Author: Rajesh Shah
Poster
2023 ASCO Annual Meeting
A combinatorial model of plasma proteins and LDCT imaging and the diagnosis of pulmonary nodules.
First Author: Meng Yang
Poster
2022 ASCO Quality Care Symposium
Rates of procedures among those with incidentally detected pulmonary nodules: A real-world data assessment.
First Author: Jeffrey C. Thompson